In ITP mice, COX-2 inhibitor hindered platelet recovery and increased the number of megakaryocytes while blocking their maturation, which is similar to the bone marrow response observed in ITP patients [17]. Here, PTGS2 is linked to autoimmune thrombocytopenic purpura.